R&D Sponsored Exploring the future: Opportunities and challenges in cell a... Rare disease treatment poses distinct challenges for physicians, patients, caregivers, and pharma companies.
Partner Content Partner Content OPEN Health invest in rare disease OPEN Health invest in rare disease
News FDA finally okays Novavax's COVID-19 jab, with restrictions The FDA has granted full approval to Novavax's COVID-19 vaccine after a delay, but has limited its use.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.